The group with CVD, consisting of 634 participants, did not seem to follow the same pattern as the healthy group
A similar revolution has occurred in the treatment of obesity and T2DM
Scenario-specific use: SAG before exercise for quick replenishment
In analysis of TTO based on parameter distributions and the valid cases, the median TTOs (Interquartile range) for SSIBs associated with semaglutide, liraglutide, dulaglutide, and exenatide were 15.5 (0.524.25, n = 18), 9.5 (0.561.5, n = 19), 35.5 (6.560.5, n = 11), and 2.5 (1.5169.5, n = 4) days, respectively (albiglutide was not included in the TTO analysis due to insufficient data)
Systemic side effects would theoretically mirror those of oral berberine if significant absorption occurred, though this remains unproven